Scott’s Directories

AUGUST 14, 2023

The world of healthcare is ever-evolving, and staying connected within this expansive industry is crucial for any professional. One effective way to ensure you remain plugged into the vital hubs of this field is by leveraging a reputable healthcare industry mailing list.

Networking 52

Networking Healthcare Healthcare Medical 52

European Pharmaceutical Review

APRIL 16, 2024

Under the terms of the new arrangement, mAbxience will develop and produce the biosimilar product using its expertise in biosimilar development and its current Good Manufacturing Practice (cGMP)-approved facilities located in Spain and Argentina.

Healthcare 80

Healthcare Healthcare Manufacturing Marketing 80

Pharmaceutical Technology

JUNE 28, 2023

Nordic healthcare providers are leading the momentum in enhancing ESG considerations. We examine the regional developments that will provide a competitive edge to pharma manufacturers.

Pharma 52

Pharma Healthcare Provider Competition Manufacturing 52

Clarify Health

OCTOBER 3, 2022

The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. We’re in phase 1 of healthcare’s price transparency movement – internet data dump – but what’s next?

Healthcare 52

Healthcare Healthcare Physicians Insurance 52

Clarify Health

OCTOBER 3, 2022

Recorded Session from the 2022 Consumer Experience & Digital Health Forum The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. “I think the healthcare market is probably very similar.

Healthcare 52

Healthcare Healthcare Physicians Insurance 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

Medicine 91

Medicine Healthcare Healthcare Pharma 91

Pharmaceutical Technology

JANUARY 15, 2023

In order to get a therapy to the market, pharma companies often outsource the drug manufacturing to specialist contract manufacturing organizations (CMOs). While Catalent Inc and PCI Pharma Services are in charge of the solid dose and packaging of Lupkynis, Lonza is manufacturing the small molecule API. EMA and NICE news.

Manufacturing 52

Manufacturing Pharmaceutical FDA Pharma 52

Pharmaceutical Technology

MARCH 21, 2023

In such turbulent times, ensuring the most efficient and cost-effective manufacturing frameworks becomes even more important. Most pharmaceutical and biotech companies outsource certain production tasks to contract manufacturing organizations (CMOs). SK Biotek is contracted to manufacture the small molecule API.

Manufacturing 59

Manufacturing Pharmaceutical Biopharma FDA 59

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. They do not have biosimilar or generic competition available in the market.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Rep-Lite

MAY 10, 2024

Technological Advancements in Healthcare Sales Technological advancements have been reshaping the landscape of healthcare sales, bringing forth a new era of innovation and efficiency. The rise of telehealth is altering the way healthcare is delivered, and medical sales are following suit.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

Eversana Intouch

NOVEMBER 20, 2023

Artificial Intelligence will also facilitate the implementation, interpretation of results and generation of personalized healthcare recommendations. Artificial Intelligence will also facilitate the implementation, interpretation of results and generation of personalized healthcare recommendations.

Marketing 90

Marketing Healthcare Healthcare Pharma 90

Healthcare Success

JULY 18, 2022

The healthcare industry is constantly evolving, and it’s essential for all healthcare businesses—and their websites—to evolve to stay competitive. Starting around five years ago, we made the strategic decision to refocus our business to serve larger healthcare clients that would benefit most from our expertise.

Healthcare 52

Healthcare Healthcare Competition Marketing 52

World of DTC Marketing

APRIL 12, 2021

Pharmaceutical manufacturers and distributors work together in a robust system to deliver high-quality products, but drug manufacturing and distribution have become increasingly complex in recent years. Outsourcing, which has become mainstream in pharma, has also led to competition that doesn’t always benefit patients.

Food and Drug Administration 187

Food and Drug Administration Prescription Pharma Manufacturing 187

European Pharmaceutical Review

NOVEMBER 30, 2023

The company stated that based on the IQVIA’s 2022 report: The impact of biosimilar competition in Europe , as of 2022 “the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5

Marketing 98

Marketing Medicine Competition Distribution 98

PM360

NOVEMBER 27, 2023

In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their combinations in today’s environment. This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the U.S. and Europe.

Manufacturing 111

Manufacturing Marketing Competition Patients 111

PM360

JUNE 26, 2023

In 2017, Algeria imposed importation restrictions on medicinal products that could be manufactured domestically, forcing manufacturers to establish local manufacturing facilities or to work with a contract manufacturing organization (CMO). Firstly, entering new markets and increasing sales should boost revenue.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

Healthcare Success

JUNE 6, 2022

Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right now—and they’re targeting your market. What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. .

Competition 109

Competition Healthcare Healthcare Marketing 109

European Pharmaceutical Review

JULY 21, 2023

Supporting European biosimilar development Continued investment in biosimilars The planned financing builds on Sandoz’s announced investment in March 2023 of $400 million in a new biologics manufacturing plant in Lendava, Slovenia. This was the largest-ever international private-sector investment in the country, according to the company.

Biopharma 91

Biopharma Manufacturing Competition Healthcare 91

Clarivate

MAY 14, 2024

Hangzhou Jiuyuan Gene Engineering (owned by Huadong Medicine) is expected to be the first domestic manufacturer to secure approval for their version of the drug once semaglutide goes off-patent in 20264 in Mainland China. Contact us to learn more about the Mainland China healthcare market and disease-specific trends.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

European Pharmaceutical Review

FEBRUARY 6, 2024

Suanfarma has announced a strategic rebranding initiative to reinforce Suanfarma’s position as a global player in the healthcare sector, both as a distributor of active pharmaceutical ingredients (APIs) and as a contract development and manufacturing organisation (CDMO) in the production of APIs.

Manufacturing 79

Manufacturing Distribution Pharmaceutical Competition 79

European Pharmaceutical Review

NOVEMBER 16, 2023

billion by 2032, according to Towards Healthcare. The organisation’s report asserted that growth of the market is being driven by numerous factors including the greater demand for biologics, the expanding biopharmaceutical industry, and the numerous advantages that single-use bioprocessing has over traditional manufacturing methods.

Marketing 76

Marketing Manufacturing Biopharma Competition 76

pharmaphorum

JANUARY 9, 2023

In some ways, it is not difficult to understand why: healthcare faced unprecedented challenge from the COVID-19 pandemic and responded in an extraordinary way. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Medicine 87

Medicine Healthcare Healthcare Pharma 87

Pharma Pathway

SEPTEMBER 23, 2022

Emcure Pharmaceuticals, We are a fast-growing Indian Pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market.

Pharmaceutical 80

Pharmaceutical Competition Manufacturing Marketing 80

PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. Key stumbling blocks include payer activation and reimbursement hurdles, regulatory complexities, tepid market adoption by healthcare professionals (HCPs), field force inefficiencies, and obstacles in engaging and adopting patients.

Biopharma 59

Biopharma Competition Prescription Marketing 59

Pharma Pathway

DECEMBER 1, 2022

Emcure Pharmaceuticals, We are a fast-growing Indian Pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market.

Engineering 78

Engineering Pharmaceutical Competition Manufacturing 78

Pharmaceutical Technology

JUNE 30, 2022

will move a step closer to becoming a key healthcare player in Turkey and global markets. Gensenta is a major manufacturer of finished pharmaceuticals and active ingredients in Turkey and is the key producer and exporter of lyophilized vials in the region. s exports and global growth strategy in the field of healthcare.

Pharma 59

Pharma Manufacturing Healthcare Healthcare 59

World of DTC Marketing

FEBRUARY 21, 2022

Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). For less wealthy nations, competition isn’t even a possibility. Reportedly, the cost of production for molnupiravir stands at about $17.74.

Pharma 218

Pharma Competition Manufacturing Medicine 218

European Pharmaceutical Review

DECEMBER 26, 2023

As a result, we can expect to see growing numbers of gene therapy developers and manufacturers adopting new techniques and technologies into their upstream processes. 2 Capabilities in suspension cell lines and proprietary cell lines are becoming increasingly important to competitiveness within the gene therapy industry.

Manufacturing 86

Manufacturing Safety Patients Competition 86

PM360

APRIL 25, 2023

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. The increase, from ASP plus 6% to ASP plus 8%, will last for five years, and may help increase access to and utilization of biosimilars and promote competition in the marketplace.

Marketing 97

Marketing Competition Government Manufacturing 97

PM360

SEPTEMBER 28, 2022

healthcare system with major implications for the Medicare Advantage and Medicare Part D programs. With major IRA provisions going into effect over the next few years, it is critical for drug manufacturers to understand and prepare for the implications to their business. The IRA affects several components of the U.S.

Government 97

Government Manufacturing Prescription Competition 97

Salesforce

OCTOBER 21, 2019

You might think that customer relationship management (CRM) software is a solution for sales teams only, but in my experience, CRM can be incredibly valuable to many different teams, especially within the healthcare and life sciences industries. A CRM built for healthcare Twenty years ago, Salesforce pioneered CRM software.

CRM 52

CRM Healthcare Healthcare Customer Relationship Management 52

Clarivate

JULY 5, 2023

The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn. This strategy is often chosen by the brand manufacturers who offer higher rebates at the net price level in exchange for better placement on formularies. The current U.S.

Marketing 97

Marketing Physicians Manufacturing Competition 97

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said.

Management 105

Management Manufacturing Sales Competition 105

Pharma Pathway

NOVEMBER 28, 2022

Emcure Pharmaceuticals, We are a fast-growing Indian Pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market.

Engineering 76

Engineering Pharmaceutical Competition Training 76

PM360

SEPTEMBER 28, 2022

PM360 spoke to Kokino about the evolution of the biosimilars market from its nascent days, why the now increased competition within the market is causing some companies to reconsider developing biosimilars, what to look for over the next few years, and how Accord’s approach is a bit different from what other companies are doing.

Competition 98

Competition Marketing Biopharma Manufacturing 98

European Pharmaceutical Review

NOVEMBER 8, 2022

The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 3) policing anticompetitive settlements between competing drug manufacturers. 3) policing anticompetitive settlements between competing drug manufacturers. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52